A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.
- Status
- WITHDRAWN
- Phase
- PHASE2
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
- Status
- TERMINATED
- Phase
- PHASE1
Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety Study of SEA-CD40 in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
- Status
- TERMINATED
- Phase
- PHASE1
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A